| Identification | Back Directory | [Name]
saquayamycin C | [CAS]
99260-70-5 | [Synonyms]
saquayamycin C
4a,8,12b-trihydroxy-9-[4-hydroxy-6-methyl-5-(6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl]-3-methyl-3-[6-methyl-5-(6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl]oxy-2,4-dihydrobenzo[a]anthracene-1,7,12-trione | [Molecular Formula]
C43H52O16 | [MOL File]
99260-70-5.mol | [Molecular Weight]
824.87 |
| Hazard Information | Back Directory | [Description]
Saquayamycin C is a glycoside of aquayamycin. | [Uses]
Saquayamycin C has antimicrobial effect, but it has weaker effect against Gram-negative bacteria. Saquayamycin C has inhibitory effect on leukemia P388 cells and Adriamycin-resistant P388 cells[1]. | [References]
[1] T Uchida, et al. Saquayamycins, new aquayamycin-group antibiotics. J Antibiot (Tokyo). 1985 Sep;38(9):1171-81. DOI:10.7164/antibiotics.38.1171 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|